“Evaluation of the Use of CGRP Monoclonal Antibodies (mAbs) in Migraine Prophylaxis in a Private Clinic”. Headache Medicine 14, no. 2 (June 30, 2023): 83–88. Accessed January 22, 2026. https://headachemedicine.com.br/hm/article/view/747.